A phase I study of olaparib in combination with capecitabine-based chemoradiation (CRT) in patients (pts) with locally advanced pancreatic cancer (LAPC)

被引：0
|
作者：
Evans, T. R. Jeffry
Eatock, Martin McKinlay
Lewsley, Liz-Anne
Kelly, Caroline
McCartney, Elaine
Duffton, Aileen
Houston, Peter
Harrison, Claire
Purcell, Colin
Ashton, Miranda
Morton, Alanna
Graham, Jill
Chalmers, Anthony J.
Thomson, Fiona
Pou, Chantevy
Bilsland, Alan
Cooke, Susie
McIntosh, David
Grose, Derek B.
机构：
[1] Univ Glasgow, Beatson West Scotland Canc Ctr, Glasgow, Lanark, Scotland
[2] Belfast City Hosp, Belfast, Antrim, North Ireland
[3] Univ Glasgow, Glasgow, Lanark, Scotland
[4] Canc Res UK Clin Trials Unit, Glasgow, Lanark, Scotland
[5] Beatson West Scotland Canc Ctr, Glasgow, Lanark, Scotland
[6] N Ireland Canc Ctr, Belfast, Antrim, North Ireland
[7] Northern Ireland Canc Ctr, Belfast, Antrim, North Ireland
[8] Univ Glasgow, Inst Canc Sci, Wolfson Wohl Canc Res Ctr, Glasgow, Lanark, Scotland
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
709
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Definitive chemoradiation therapy with capecitabine in locally advanced pancreatic cancer
    Kim, Hyo Song
    Yi, Seong Yoon
    Jun, Hyun Jung
    Lee, Jeeyun
    Park, Se Hoon
    Lee, Jong Kyun
    Lee, Kyu Taek
    Lee, Kwang Hyuck
    Choi, Dong Wook
    Choi, Seong-Ho
    Heo, Jin Seok
    Park, Young Suk
    Lim, Ho Yeong
    Kang, Won Ki
    Park, Hee Chul
    Lim, Do Hoon
    Park, Joon Oh
    ANTI-CANCER DRUGS, 2010, 21 (01) : 107 - 112
  • [22] Phase II study of induction chemotherapy with fixed dose rate (FDR) gemcitabine and cisplatin followed by concurrent chemoradiation with capecitabine for locally advanced pancreatic cancer (LAPC)
    Kim, J.
    Im, S.
    Park, H.
    Chie, E.
    Hwang, J.
    Kim, J.
    Kim, T.
    Bang, Y.
    Ha, S.
    Yoon, Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [23] Phase I study of capecitabine and erlotinib with radiotherapy in locally advanced nonoperable pancreatic cancer
    Jiang, Y.
    Kimchi, E.
    Gusani, N. J.
    Mackley, H. B.
    Staveley-O'Carroll, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [24] Interferon (IFN)-based chemoradiation (CRT) as initial therapy (RX) for locally advanced pancreatic cancer (LAPC): A single-center experience.
    Picozzi, V. J.
    Boone-Hill, N. K.
    Song, G.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [25] Preoperative chemoradiation with nimotuzumab and capecitabine in patients with locally advanced rectal cancer: A phase II study
    Zhu, Yuan
    Liu, Luying
    Luo, Jialing
    Li, Dechuan
    Zhu, Yuping
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [26] Gemcitabine-based or capecitabine-based chemoradiotherapy for locally advanced pancreatic cancer (SCALOP): a multicentre, randomised, phase 2 trial
    Mukherjee, Somnath
    Hurt, Christopher N.
    Bridgewater, John
    Falk, Stephen
    Cummins, Sebastian
    Wasan, Harpreet
    Crosby, Tom
    Jephcott, Catherine
    Roy, Rajarshi
    Radhakrishna, Ganesh
    McDonald, Alec
    Ray, Ruby
    Joseph, George
    Staffurth, John
    Abrams, Ross A.
    Griffiths, Gareth
    Maughan, Tim
    LANCET ONCOLOGY, 2013, 14 (04): : 317 - 326
  • [27] The PACT trial: Interim results of a randomized trial of TNFerade biologic plus chemoradiation (CRT) compared to CRT alone in locally advanced pancreatic cancer (LAPC).
    Senzer, N.
    Rosemurgy, A.
    Javle, M.
    Reid, T.
    Posner, M. C.
    Chang, K. J.
    Owens, M.
    Shirinian, M.
    Stephenson, J.
    Hecht, J. R.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 203S - 203S
  • [28] Gemcitabine plus Nab-Paclitaxel with chemoradiation in locally advanced pancreatic cancer (LAPC)
    Olowokure, Olugbenga
    Torregroza-Sanchez, Maria Patricia
    Bedoya-Apraez, Ivan Dario
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2013, 4 (02) : E16 - E18
  • [29] Phase I study of trametinib with neoadjuvant chemoradiation (CRT) in patients with locally advanced rectal cancers (LARC).
    Wu, Christina Sing-Ying
    Williams, Terence Marques
    Wei, Lai
    Umar, Hamida
    Mikhail, Sameh
    Ciombor, Kristen Keon
    Chan, Emily
    Noonan, Anne M.
    Roychowdhury, Sameek
    El-Dika, Samer S.
    Krishna, Somashekar
    McCarthy, Sean T.
    Arnold, Mark
    Harzman, Alan
    Abdel-Misih, Sherif
    Cirocco, William
    Traugott, Amber
    Bekaii-Saab, Tanios S.
    Wuthrick, Evan John
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [30] A phase I study of erlotinib in combination with chemoradiation (CRT) for unresectable, locally advanced non-small cell lung cancer (NSCLC).
    Hoffman, PC
    Mauer, AM
    Haraf, DC
    Lester, EP
    Szeto, LL
    Vokes, EE
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 648S - 648S
12345